Tilman T. Rau

8.0k total citations · 2 hit papers
113 papers, 3.8k citations indexed

About

Tilman T. Rau is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Tilman T. Rau has authored 113 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 28 papers in Cancer Research and 25 papers in Molecular Biology. Recurrent topics in Tilman T. Rau's work include Genetic factors in colorectal cancer (17 papers), Endometrial and Cervical Cancer Treatments (17 papers) and Ovarian cancer diagnosis and treatment (11 papers). Tilman T. Rau is often cited by papers focused on Genetic factors in colorectal cancer (17 papers), Endometrial and Cervical Cancer Treatments (17 papers) and Ovarian cancer diagnosis and treatment (11 papers). Tilman T. Rau collaborates with scholars based in Germany, Switzerland and United States. Tilman T. Rau's co-authors include Arndt Hartmann, Joseph W. Carlson, E. Epstein, Marie-Hélène Wasmer, Philippe Krebs, Grzegorz Burnat, Lukas F. Mager, Abbas Agaimy, Jessica N. McAlpine and Sara Y. Brucker and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Tilman T. Rau

107 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

2019 255 citations Alicia León‐Castillo, Remi A. Nout et al. The Journal of Pathology profile →
Interpretation of somatic POLE mutations in endometrial carcinoma

2019 244 citations Alicia León‐Castillo, Heidi Britton et al. The Journal of Pathology profile →

Peers

Countries citing papers authored by Tilman T. Rau

Since Specialization

Citations

This map shows the geographic impact of Tilman T. Rau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman T. Rau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman T. Rau more than expected).

Fields of papers citing papers by Tilman T. Rau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilman T. Rau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman T. Rau. The network helps show where Tilman T. Rau may publish in the future.

Co-authorship network of co-authors of Tilman T. Rau

This figure shows the co-authorship network connecting the top 25 collaborators of Tilman T. Rau. A scholar is included among the top collaborators of Tilman T. Rau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilman T. Rau. Tilman T. Rau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer—Introducing the Prospective “ProFam-Risk” Study 2026 ·European Urology Open Science ·(unknown), Matthias Boschheidgen, Gerald Antoch, (unknown), André Karger, (unknown), (unknown), (unknown), (unknown), (unknown), Tanja Fehm, (unknown), Tilman T. Rau, (unknown)	1
2	Added prognostic value of sentinel lymph node mapping in endometrial cancer to molecular subgroups 2025 ·Gynecologic Oncology ·Franziska Siegenthaler, Sara Imboden, (unknown), (unknown), Wiebke Solaß, (unknown), (unknown), (unknown), (unknown), (unknown), Stefan Mohr, Andrea Papadia, Maria Anokhina, (unknown), Tilman T. Rau, Michael D. Mueller	1
3	Real-World Data on Institutional Implementation of Screening for Mismatch Repair Deficiency and Lynch Syndrome in Endometrial Cancer Patients 2024 ·Cancers ·(unknown), (unknown), Wiebke Solaß, (unknown), Manuela Rabaglio, (unknown), Tilman T. Rau, (unknown), Laura Knabben, Sara Imboden, Michael D. Mueller, Franziska Siegenthaler	0
4	Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma 2023 ·Frontiers in Medicine ·(unknown), Luca Noti, (unknown), José A. Galván, Inti Zlobec, Michael Müller, Sara Imboden, Franziska Siegenthaler, Joseph W. Carlson, Teijo Pellinen, Victoria Heredia-Soto, Ignacio Ruz‐Caracuel, David Hardisson, Andrés Redondo, Marta Mendiola, Tilman T. Rau	0
5	Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral zone in men without prostate cancer 2023 ·European Journal of Radiology ·(unknown), (unknown), Martin J. Thomas, Matthias Boschheidgen, (unknown), T. Ullrich, Tilman T. Rau, Iréne Esposito, Gerald Antoch, Peter Albers, (unknown), Lars Schimmöller	4
6	Communicator-Driven Data Preprocessing Improves Deep Transfer Learning of Histopathological Prediction of Pancreatic Ductal Adenocarcinoma 2022 ·Cancers ·(unknown), Lena Häberle, (unknown), Haifeng C. Xu, (unknown), (unknown), Tilman T. Rau, Aleksandra A. Pandyra, Karl S. Lang, Iréne Esposito, Philipp A. Lang	10
7	Endometriosis and Isthmocele: Common or Rare? 2022 ·Journal of Clinical Medicine ·(unknown), Sara Imboden, Konstantinos Nirgianakis, Franziska Siegenthaler, Tilman T. Rau, Michael D. Mueller	15
8	Treatment following hysteroscopy and endometrial diagnostic biopsy increases the chance for live birth in women with chronic endometritis 2021 ·American Journal of Reproductive Immunology ·Vera Ruth Mitter, (unknown), Tilman T. Rau, Tessa Gillon, Michael D. Mueller, Marcel Zwahlen, Michael von Wolff, Alexandra Kohl Schwartz	13
9	GPR15 Facilitates Recruitment of Regulatory T Cells to Promote Colorectal Cancer 2021 ·Cancer Research ·Alexandra Adamczyk, Eva Pastille, Jan Kehrmann, Vivian Vu, Robert Geffers, Marie-Hélène Wasmer, Stefan Kasper, Martin Schüler, Christian Lange, (unknown), Tilman T. Rau, Diana Klein, Wiebke Hansen, Philippe Krebs, Jan Buer, Astrid M. Westendorf	23
10	MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer 2020 ·Cancers ·(unknown), François Richard, (unknown), Tilman T. Rau, José A. Galván, Christine Desmedt, Albert Santamaria‐Martínez, Curzio Rüegg	14
11	Tumour budding and CD8⁺ T cells: ‘attackers’ and ‘defenders’ in rectal cancer with and without neoadjuvant chemoradiotherapy 2020 ·Histopathology ·(unknown), (unknown), Tilman T. Rau, José A. Galván, Irıs D. Nagtegaal, Heather Dawson, Annika Blank, Andreas Köhler, Alessandro Lugli, Inti Zlobec	7
12	Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort 2019 ·Scientific Reports ·Zsuzsanna Varga, Qiyu Li, Wolfram Jochum, (unknown), Tilman T. Rau, (unknown), Hanne Hawle, Dirk Klingbiel, Beat Thuerlimann, Thomas Ruhstaller	10
13	Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas breakdown → 2019 ·The Journal of Pathology ·Alicia León‐Castillo, (unknown), Remi A. Nout, Vincent T.H.B.M. Smit, Jessica N. McAlpine, Melissa K. McConechy, Stefan Kommoss, Sara Y. Brucker, Joseph W. Carlson, E. Epstein, Tilman T. Rau, Robert A. Soslow, Raji Ganesan, Xavier Matías‐Guiu, Esther Oliva, Beth Harrison, David N. Church, C. Blake Gilks, Tjalling Bosse	255
14	Interpretation of somatic POLE mutations in endometrial carcinoma breakdown → 2019 ·The Journal of Pathology ·Alicia León‐Castillo, Heidi Britton, Melissa K. McConechy, Jessica N. McAlpine, Remi A. Nout, Stefan Kommoss, Sara Y. Brucker, Joseph W. Carlson, E. Epstein, Tilman T. Rau, Tjalling Bosse, David N. Church, C. Blake Gilks	244
15	Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells 2019 ·Journal of Cancer Research and Clinical Oncology ·J. Böhm, Julienne K. Muenzner, (unknown), (unknown), Katharina Erlenbach‐Wünsch, Susanne Merkel, Roland S. Croner, Tilman T. Rau, Carol Geppert, Arndt Hartmann, Adriana Vial Roehe, Regine Schneider‐Stock	21
16	Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis 2016 ·International Journal of Molecular Sciences ·Roland S. Croner, (unknown), Metodi V. Metodiev, Peter Jo, Michael Ghadimi, Vera Schellerer, (unknown), (unknown), Tilman T. Rau, Michael Stürzl, Elisabeth Naschberger, Klaus E. Matzel, Werner Hohenberger, Friedrich Lottspeich, Josef Kellermann	22
17	miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis 2015 ·Inflammatory Bowel Diseases ·Natalya Benderska, (unknown), (unknown), Tilman T. Rau, Clemens Neufert, Sven Wach, Fabian B. Fahlbusch, Manfred Rauh, Ralph M. Wirtz, Abbas Agaimy, (unknown), (unknown), Petra Rümmele, (unknown), Maria Gazouli, Arndt Hartmann, Regine Schneider‐Stock	54
18	Comparative microRNA Profiling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing 2013 ·Molecular Cancer Research ·Martin Hart, Elke Nolte, Sven Wach, Jaroslaw Szczyrba, Helge Täubert, Tilman T. Rau, Arndt Hartmann, Friedrich A. Grässer, Bernd Wullich	74
19	Inhibition of Tumor Promotion by Parthenolide: Epigenetic Modulation of p21 2012 ·Cancer Prevention Research ·Akram Ghantous, (unknown), Tilman T. Rau, Hala Gali‐Muhtasib, Regine Schneider‐Stock, Nadine Darwiche	26
20	The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells 2012 ·Molecular Cancer Therapeutics ·Vikas Sehdev, Dunfa Peng, Mohammed Soutto, M. Kay Washington, Frank Revetta, Jeffrey Ecsedy, Alexander Zaika, Tilman T. Rau, Regine Schneider‐Stock, Abbes Belkhiri, Wael El‐Rifai	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact